XML 34 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Intangibles, Net and Goodwill
12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangibles, Net and Goodwill Intangibles, Net and Goodwill
Intangibles, net, consisted of the following:
 December 31, 2020
(in thousands)Amortization
Method
CostAccumulated AmortizationNet
TrademarksStraight-Line$13,540 $(10,958)$2,582 
Customer relationshipsAccelerated96,865 (93,770)3,095 
Currently marketed productStraight-Line142,900 (5,053)137,847 
LicensesStraight-Line85,800 (4,008)81,792 
Developed technologyStraight-Line2,400 (144)2,256 
IPR&DN/A148,440 — 148,440 
Total$489,945 $(113,933)$376,012 

December 31, 2019
(in thousands)Amortization
Method
CostAccumulated AmortizationNet
TrademarksStraight-Line$13,540 $(10,407)$3,133 
Customer relationshipsAccelerated99,019 (94,816)4,203 
Total$112,559 $(105,223)$7,336 
The Company recorded amortization expense for its intangible assets of $10.8 million, $1.8 million and $2.6 million for the years ended December 31, 2020, 2019 and 2018, respectively.
The Company performed its annual impairment test of its IPR&D assets as of October 31, 2020. As a result of a timing delay in the development of an AZEDRA IPR&D asset due to the impact of COVID-19, the Company determined that the carrying value of $18.3 million exceeded the fair value of the asset. Accordingly, the Company recorded a non-cash impairment charge of $2.7 million for the year ended December 31, 2020 in research and development expenses in the consolidated statements of operations. The estimated fair value of the AZEDRA IPR&D asset was determined based on the present values of the expected cash flows. The Company used a discount rate of 23.0% and cash flows that have been probability adjusted to reflect the risks of product commercialization, which the Company believes are appropriate and representative of market participant assumptions.
The below table summarizes the estimated aggregate amortization expense expected to be recognized on the above intangible assets:
(in thousands)Amount
2021$18,628 
202218,504 
202317,898 
202417,824 
202517,766 
2026 and thereafter 136,952 
Total$227,572 

Goodwill by reportable segment consisted of the following:

(in thousands)U.S.Total
Balance, January 1, 2020$15,714 $15,714 
Acquisition(1)
42,918 42,918 
Balance, December 31, 2020$58,632 $58,632 

(1)Refer to Note 8, “Business Combinations” for additional details related to the Progenics acquisition